| Analysis at 2/19/2026 | YTD | 1 year | 3 years | 5 years |
|---|---|---|---|---|
| Performance | 3.84% | 24.26% | 42.43% | 50.13% |
| Analysis at 2/19/2026 | 1 year | 3 years | 5 years |
|---|---|---|---|
| Volatility | 23.97% | 17.87% | 16.97% |
| Negative volatility | 13.42% | 10.29% | 10.10% |
| Sharpe | 0.74 | 0.50 | 0.45 |
| Sortino | 1.33 | 0.88 | 0.75 |
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | ||
| Candriam Eq. L Biotechnology C EUR | 4.68% | 4.91% | 3.49% | 9.35% | 22.09% | 3.84% | |
| Equity Sector - Biotechnology | 16.35% | 15.35% | 0.35% | 6.70% | 8.38% | 4.40% | |